Valuation: Tactile Systems Technology, Inc.

Capitalization 225M 192M 179M 167M 308M 19.27B 343M 2.17B 818M 9.04B 842M 825M 33.1B P/E ratio 2025 *
17.3x
P/E ratio 2026 * 12.4x
Enterprise value 225M 192M 179M 167M 308M 19.27B 343M 2.17B 818M 9.04B 842M 825M 33.1B EV / Sales 2025 *
0.72x
EV / Sales 2026 * 0.67x
Free-Float
98.05%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.10%
1 week-4.24%
Current month-4.34%
1 month-1.92%
3 months-27.34%
6 months-44.35%
Current year-43.37%
More quotes
1 week 9.6
Extreme 9.6
10.32
1 month 9.6
Extreme 9.6
10.52
Current year 8.61
Extreme 8.6098
18.51
1 year 8.61
Extreme 8.6098
21.1
3 years 6.52
Extreme 6.52
26.11
5 years 6.28
Extreme 6.28
64.53
10 years 6.28
Extreme 6.28
76.63
More quotes
Manager TitleAgeSince
Chief Executive Officer 59 30/06/2024
Director of Finance/CFO 50 19/03/2023
Chief Operating Officer - 31/10/2021
Director TitleAgeSince
Chairman 65 31/08/2015
Director/Board Member 66 19/09/2017
Director/Board Member 59 31/12/2020
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+0.16%-4.24%-23.92%+35.85% 225M
-0.01%+0.01%+0.01%+59.50% 12.57B
-0.64%-3.69%+19.63%+94.45% 9.16B
-0.51%-3.52%+45.23%+26.34% 8.68B
-0.78%+0.98%+34.95%+193.72% 5.79B
-0.80%-2.99%+0.70%-20.74% 5.28B
+1.16%+0.11%-5.13%+42.83% 4.81B
+0.05%-.--%+45.93%+8.45% 4.7B
-0.81%+0.75%-5.34%-6.87% 4.16B
-1.84%+15.97%+73.88%+60.35% 1.9B
Average -0.41%+1.25%+18.59%+49.39% 5.73B
Weighted average by Cap. -0.35%-0.35%+18.90%+55.76%
See all sector performances

Financials

2025 *2026 *
Net sales 310M 266M 247M 230M 425M 26.61B 474M 3B 1.13B 12.48B 1.16B 1.14B 45.71B 337M 288M 268M 250M 461M 28.88B 514M 3.26B 1.23B 13.55B 1.26B 1.24B 49.61B
Net income 13.23M 11.33M 10.55M 9.83M 18.12M 1.14B 20.22M 128M 48.19M 532M 49.61M 48.59M 1.95B 18.52M 15.86M 14.77M 13.76M 25.36M 1.59B 28.3M 179M 67.47M 745M 69.47M 68.03M 2.73B
Net Debt - -
More financial data * Estimated data
Logo Tactile Systems Technology, Inc.
Tactile Systems Technology, Inc., doing business as Tactile Medical, is a medical technology company providing therapies for people with chronic disorders. The Company's areas of therapeutic focus are vascular disease, oncology and providing airway clearance therapy for those suffering from chronic respiratory conditions. It is developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease. It markets Flexitouch Plus and Entre Plus systems as at-home therapies for the treatment of lymphedema and chronic venous insufficiency. The Company markets AffloVest as an at-home therapy intended to promote airway clearance. Its Flexitouch Plus system is a fully automated, programmable, advanced pneumatic compression device. The Company's Entre system is a basic pneumatic compression device. Kylee, its free mobile application, helps patients learn about lymphedema.
Employees
1,037
More about the company
Date Price Change Volume
16/07/25 9.690 $ +0.31% 75,776
15/07/25 9.660 $ -3.78% 327,411
14/07/25 10.04 $ +0.80% 139,355
11/07/25 9.960 $ -2.92% 132,891
10/07/25 10.26 $ +1.28% 124,891

Delayed Quote Nasdaq, July 16, 2025 at 06:22 pm

More quotes
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
9.660USD
Average target price
13.00USD
Spread / Average Target
+34.58%
Consensus

Quarterly revenue - Rate of surprise